Financial News

Financial Report: INC Research

Revenues up 23% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

INC Research   4Q Revenues: $402.9 million (+23%) 4Q Earnings: $30.7 million (loss of $53.2 million 4Q14) FY Revenues: $1.4 billion (+19%) FY Earnings: $117 million (loss of $23.5 million FY14) Comments: Book-to-bill was 1.2x for the quarter and 1.3x for the year. Net new business awards were $297.4 million in the quarter and $1.18 billion for the year. Revenue growth during both the fourth quarter and fiscal year 2015 was driven primarily by continued strong awards over the last ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters